Summary
The provided claims are largely about grapefruit/fruit effects and nutrient interactions, but the supplied label excerpts (Sections 1, 1.1, 14.1, 5.5) do not contain information to verify these statements. As a result, most claims are unsupported/absent from the provided label text for this audit scope.
Category Scores
Accurate Statements
Lipitor (atorvastatin) is a statin medication used to lower cholesterol levels in the blood.
Not supported or verifiable from the provided excerpts (Sections 1, 1.1, 14.1, 5.5 do not state statin mechanism or cholesterol-lowering description).
Unsupported Statements
Grapefruit and grapefruit juice can increase the levels of atorvastatin in the bloodstream.
No grapefruit-related interaction information is present in the provided label excerpts.
A compound in grapefruit called furanocoumarin can block an enzyme in the liver that breaks down atorvastatin.
No furanocoumarin/mechanism-of-metabolism statements are present in the provided label excerpts.
Oranges do not contain significant amounts of furanocoumarins.
No citrus/fruit composition statements are present in the provided label excerpts.
Eating a single orange or drinking a small amount of orange juice did not affect the absorption or metabolism of atorvastatin.
No orange/absorption/metabolism study or related interaction statements are present in the provided label excerpts.
Consuming large amounts of citrus fruits, including oranges, may affect the absorption of other nutrients such as calcium and iron.
No nutrient absorption effects from citrus fruits are present in the provided label excerpts.
Contradictions
Important Omissions
Label-supported dosing/administration instructions and interaction warnings/contraindications for atorvastatin are not evaluated because the provided excerpts do not include relevant sections (e.g., drug interactions).
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Medium
Multiple claims describe grapefruit/orange effects on atorvastatin exposure and absorption, but these interaction details are not supported by the supplied label excerpts. Without label support in the provided text, the risk of misinformation is elevated for medication-administration/safety contexts.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Partially Aligned
Primary Issue
Interaction claims (grapefruit/orange effects, furanocoumarin mechanism, nutrient absorption) are not present in the provided FDA label excerpts (Sections 1, 1.1, 14.1, 5.5).
Suggested Improvement
Limit statements to information actually contained in the provided label text for this audit scope, or provide the specific label sections that cover drug interactions/food effects before evaluating or repeating those claims.